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Three strains of autoimmune mice, MRL/Mp-lpr/lpr, C3H/HeJ-gld/gld, and
BXSB/Mp-Yaa, have been established from spontaneous mutant mice (1-5). They
have served as models for pathological, immunological, and molecular biological
studies on autoimmune diseases and proliferation ofabnormal lymphocytes (6-9).
Several mice with massive lymph node hyperplasia were found in the CBA/Kljms
colony maintained at the LaboratoryAnimal Research Center, Institute ofMedical
Science, University of Tokyo. The CBA/Kl mice were originally introduced from
the Karolinska Institute in Sweden in 1969 and have been maintained by sister x
brother mating (10). In 1983, the specific pathogen-free (SPF)1 colony was estab-
lished by Caesarean section. We discovered these diseased mice in this colony in
1985. Theywere mated with eachotherto investigate the developmentoflymphade-
nopathyin their offspring. Asaresult, they all developed massive lymphadenopathy
composedofclearly enlarged superficialandinternallymph nodes and palpablespleno-
megaly before 5 mo of age. These mice have been maintained as a mutant strain
by brother x sister mating and confirmed to transmit this mutation stably. Thus,
genetic studies were conducted by crossing them with various strains of mice. As
presented in this paper, the mutant strain ofmicehasbeenconfirmed tohave a new
allele ofthelprlocusthat interacts with thegldgene toinduce lymphoid hyperplasia.
In supportofthegenetic conclusion, the serologicaland immunopathological studies
demonstrated that CBA/K1Jms mutants were very similar to C3H/HeJ-lpr/lpr and
C3H/HeJg1d/gldmice in anomalousphenotypes, includinghypergammaglobulinemia,
high titers ofanti-DNA antibodies, and surfacemarkers oflymphoid cells from en-
larged lymph nodes.
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Materials and Methods
Mice. CBA/Kljms (CBA-+), mutant CBA/K1Jms (CBS-m), C3H/Helms (C3H-+),
C57BL6Jms(B6-+), DDD/1-nu/nu (DDD-nu), SWR/JJms (SWR+), and NZW/NJms (NZW +)
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I Abbreviation used in this paper: SPF, specific pathogen free.
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mice maintained at the Laboratory Animal Research Center (10) were used. These strains
of mice have not developed lymphadenopathy. MRL/MpJ (MRL-+), MRL/MpJ-lpr/Ipr
(MRL-Ipr), C3H/HeJ-Ipr/1pr(C3H-Ipr), and C3H/HeJ-gld/gld(C3H-gld) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME), bred at our center, and used. Most mice
were kept under SPF conditions in a light cycle (12 h light and 12 h dark)- and temperature-
controlled room.
Observation ofLymphadenopathy.
￿
F,, F2, and backcross mice from crosses between CBA-m
and another strain ofmice were examined by palpation for enlargement of superficial lymph
nodes and spleens weekly after 2 mo of age. Most mice were killed at the age of 5-6 mo,
since all CBA-m mice had shown the first signs of lymphadenopathy before 3 mo and had
visible enlarged lymph nodes at 4 mo of age. Some mice were observed up to 1 yr of age
for the survival, development of lymphadenopathy, and progress of the disease. Especially,
CBA-m, C311-gld, C3H-Ipr, (CBA-m x C3H-Ipr)F,, and (CBA-m x C3H-gld)F, mice were
killed by chloroform overdose for weight determinations of lymph nodes and spleens at 2,
3, 5, 10, or 12 mo ofage. Lymph nodesand spleens were excised, cleared ofthe surrounding
tissue, and weighed wet separately. As all lymph nodes except the mesenteric lymph nodes
never exceeded 5 mg in weight in CBA-+ mice, those under this weight, or missed because
of their impossible discrimination from the surrounding tissue at excision, were expressed
as <5 mg in weight for calculation of the means. The weights of the cervical, axillary, brachial,
and inguinal lymph nodeswere added and presented as the combined superficial lymph node
weight, and those ofthe mediastinal, renal, lumbar, and sciatic lymph nodeswere also added
and presented as the combined internal lymph node weight. The mesenteric lymph node
weight was presented separately, sinceits determination was not so accurate because ofdifficulty
in distinguishing the nodesfrom the surrounding fat tissue unless enlarged, and additionally
because they are far larger than the other internal lymph nodes.
Antibodies.
￿
A panel of rat mAbs was used as culture supernatants. Both AT83 specific
for Thy-1.2 (11) and GK-1.5 directed against L3T4 (12) were originally supplied by F. Fitch
(University of Chicago, Chicago, IL). The 53-6.7 was directed against Lyt-2 (13). The hy-
bridoma that secretes mAb against B220(3A1) was purchased from the American Type Cul-
ture Collection (Rockville, MD). FITC-conjugated goat F(ab')2 anti-mouse IgM and FITC-
conjugated goat anti-rat IgG were purchased from Tago Inc. (Burlingame, CA). Alkaline
phosphatase-conjugated anti-mouse IgM and IgG, specific for h and ti chains, respectively,
were obtained from Cappel Laboratories (Malvern, PA).
Preparation of Cell Suspensions.
￿
Lymph nodes were excised aseptically from normal, mu-
tant, and hybrid mice aged 5-6 mo, and single cell suspensions were prepared in MEM con-
taining 3% FCS. Lymph node cells were from a pool ofcervical, axillary, inguinal, and mesen-
teric nodes. Their viability as determined by trypan blue exclusion was >90%.
Immunofuorescence Staining and Flow Cytometry.
￿
Direct and indirect methods were used for
immunofluorescent staining of cells with FITC-conjugated polyclonal antibodies. For direct
assay, 106 cells were suspended in 100 Al of PBS containing 3% FCS and 0.1% NaN3, and
incubated with FITC-conjugated goat anti-mouse IgM for 30 min at 4°C. The cells were
washed three times with the medium. For indirect assay, 10, cells were incubated in the same
medium for 30 min at 4'C with hybridoma supernatants containing mAbs specific for Thy-
1.2, L3T4, Lyt-2, and Ly-5(B220). After washing twice, the cells were incubated with FITC-
conjugated anti-rat IgG in 100 pl of the medium for 30 min at 4°C. Control cells were treated
with FITC-conjugated reagent alone. After washing an additional three times, the cells were
analyzed by flow cytometry (Spectrum 111; Ortho Diagnostics Systems, Inc., Westwood, MA),
and the data were collected using a logarithmic amplification.
Serum Ig and Anti-DNA Antibody Determinations.
￿
Blood was collected by heart puncture from
normal, mutant, and hybrid mice aged 6 mo, and serum was separated for assays. IgM and
IgG concentrations were determined by single radial immunodiffusions (The Binding Site,
Birmingham, UK). Anti-ssDNA and anti-dsDNA antibodies were determined by ELISA,
described by Kanai et al. (14). Briefly, 96-well microtiter plates were first coated with poly-t.-
lysine and subsequently with purified nucleic acids. They were blocked with Tris-buffered
saline (TBS; 25 mM Tris, 140 mM NaCl, pH 7.4) containing 5% FCS and 0.05% Tween
20. Sera were 50-fold diluted with TBS containing FCS alone and assayed. After each incuba-tion, theplates were washed extensively with TBScontaining Tween alone. Boundantibodies
were detected with alkaline phosphatase-conjugated anti-mouse IgM or IgG usingp-nitro-
phenylphosphate (Sigma Chemical Co., St. Louis, MO) as a substrate. Antibody levels were
expressed as the absorbance at 405 nm (Aa0s) (ImmunoReader; Nippon InterMed, Tokyo,
Japan).
Histology.
￿
Main organs from 6-mo-old CBA-mmice were fixedin l0olo formalin in PBS,
embedded in paraffin, sectioned at 4km, and stained with hematoxylin and eosin for histo-
logic examination.
Results
1 yr Follow-up of CBA-mMice.
￿
36 males and 26 females from the CBA-m colony
under SPF conditions were observed for the development of lymphadenopathy and
mortalityup to 1 yr of age. In all mice, theenlargement of superficial lymph nodes
commenced at -2.5 mo of age with a tendency of earlier onset in cervical than in
inguinal lymph nodes, and splenomegaly was clearly palpable after 3 mo of age.
The first death was recorded at 19 and 29 wk of age, and the survival rate at 1 yr
of agewas 61.1 and 46.2% in males andfemales, respectively (Fig. 1). All nonmutant
counterparts survive >1 yr under similar conditions.
CBA-mmice with the abovemacroscopicpathological characters were used in genetic
studies. Breeding tests involving Ft, F2, and backcross mice were conducted in order
to clarify the genetic control of the mutant trait. Practically the same results were
obtained with regard to the development and progression of lymphadenopathy in
the crosses ofmutant maleswith normal females, and in the reverse crosses, demon-
strating the autosomal inheritance ofthe disease. Thus, the pooled results from the
reciprocal crosses are presented in the tables.
Lymphadenopathy in FI Progeny.
￿
30, 86, 21, 4, 26, 37, and 32 male and female
Fi mice were obtained by mating CBA-m to B6-+, CBA-+, C3H-+, DDD-nu,
MRL-+, NZW-+, or SWR+ mice, respectively, and observed for the presence or
absenceofenlarged lymphnodes andsplenomegaly by palpation for a 5-6-mo period
and by autopsy at the end of this period, since the prolonged observation up to 1 yr
of age had been confirmed to have no influence on the outcome in (CBA-m x
CBA-+)Fi mice. None of the total number of 236 FI mice showed any sign of lym-
phoid hyperplasia in support of the recessive nature of the mutation.
Lymphadenopathy in F2 Progeny.
￿
F2 mice derived from the combinations of CBA-
m x B6-+, CBA-m x CBA-+, CBA-m x C3H-+, CBA-m x MRL-+, and CBA-
m x NZW-+ were observed as mentioned above (Table I). The number of mice
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FIGURE 1.
￿
Survival ofCBA-m male (solid line) and
female (dotted line) mice during 1-yr observation.522
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TABLE I
Incidence ofLymphadenopathy in F2 Populations Arising
from Crosses between CBA-m and B6- +, CBA- + ,
C3H- +, MRL- +, or NZW- + Mice
with massive lymphadenopathy and that ofnormal mice were 39 and 127 in (CBA-
m x B6-+)F2, 40 and 112 in (CBA-m x CBA-+)F2, 13 and 26 in (CBA-m x
C3H-+)F2, 16 and 52 in (CBA-m x MRL-+)F2, and 13 and 39 in (CBA-m x
NZW+)F2, respectively. When these results were combined, 121 F2 mice were affected
bythehereditary disease, but356were normal. Theratioofthe diseased tonondiseased
mice was 1:2.94. Therefore, the hereditary disease was verified to be transmitted by
a single autosomal recessive gene in accordance with the mendelian law.
Lymphadenopathy in Backsross Progeny. (CBA-m x B6-+)Fl and (CBA-m x
CBA-+)F1 were backcrossed to CBA-m mice, and their offspring were observed as
mentioned above (Table II). In the former backcross, 108, but not 92, mice developed
obvious lymphadenopathy. The latter gave a similar result: 50, but not 53, mice had
enlarged lymph nodes and spleens. Collectively, 158, but not 145, backcross mice were
hereditarily diseased. Their ratio was 1:0.92. This result also supports the above con-
clusion, the single autosomal recessive gene control.
TABLE II
Incidence of Lymphadenopathy in Backcross Populations Arising
from Crosses between CBA-m and CBA- + or B6- + Mice
Crosses
(CBA-m x B6-+)F2
Sex
Male
No. of
mice observed
82
No. with
lymphadenopathy
19 (23.2)
Female 84 20 (23.8)
(CBA-m x CBA-+)F2 Male 70 17 (24.3)
Female 82 23 (28.0)
(CBA-m x C3H-+)F2 Male 26 9 (34.6)
Female 13 4 (30.8)
(CBA-m x MRL-+)F2 Male 45 11 (24.4)
Female 23 5 (21 .7)
(CBA-m x NZW-+)F2 Male 29 9 (31 .0)
Female 23 4(17.4)
Total 477 121 (25 .4)
Crosses Sex
No. of
mice observed
No. with
lymphadenopathy
(CBA-m x CBA-+)Fj Male 108 67 (62.0)
x CBA-m Female 92 41 (44.6)
(CBA-m x B6-+)Fj Male 44 21 (47 .7)
x CBA-m Female 59 29 (49.2)
Total 303 158 (52.1)MATSUZAWA ET AL.
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Allelism ofthe Mutant Gene with gld, lpr, and Yaa.
￿
So far, three mutant genes, gld,
lpr, and Yaa, have been reported to be involved in lymphadenopathy with autoim-
mune disease in mice (1-5). Since the Yaa gene is linked to Y chromosome (1, 4,
5), the new mutant gene is clearly considered to be different from it. Bothgld and
lpr are autosomal recessive genes (1). The former is mapped on chromosome 1 (3,
15), but the genetic linkage of the latter has not been established, despite the fact
that47% ofthe autosomal genomeshasbeen tested (2, 16). Lymph nodeand spleen
enlargements in mice homozygous for either gene progressed in a similar course
as in the mutant mice. Therefore, a question arose as to whether the mutant gene
is allelicwithgldor lpr, or isdifferent from both. To answer the question, 101 (CBA-
m x C3H-gld)F1, 77 (CBA-m x C3H-lpr)Fj, and 30 (CBA-m x MRL-lpr)Fi mice
were observed for the development oflymphadenopathy as mentioned above. Con-
trary to our expectations, all these hybrids developed palpable and visible lymph-
adenopathy(Table III), althoughthelymphnode andspleen enlargements were smaller
in severity in (CBA-m x C3H-gld)Fl mice. All (C3H-gld x C3H-lpr)Fl mice were
completely free from illness in palpation andat autopsy, in accord with thedifferent
allelism ofgldand lpr(2). All other control hybrids were negative for lymphadenop-
athy. Tofurther analyze the allelismofthe mutant gene withgldor lpr, backcrossing
tests were conductedbetween CBA-+, C3H-+, CBA-m, orC3H-gldand(CBA-m x
C3H-gld)F,, and between CBA-+ or CBA-m and (CBA-m x C3H-lpr)Fi mice
(Table IV). 30 of 137 (21.9%) and 7 of39 (17.9%) mice developed moderate lymph-
adenopathy in the ([CBA-m x C3H-gld]F, x CBA-+) and ([CBA-m x C3H-
g1djF, x C3H-+) backcross populations, respectively. In addition, 89 of 120 (74.2%)
and 37 of47 (78.7%) mice were affected with lymphadenopathy in the ([CBA-m x
C3H-gld]Fi x CBA-m) and ([CBA-m x C3H-gld]F, x C3H-gld) backcross popula-
tions, respectively. Very significantly, 26, 11, and 10 ([CBA-m x C3H-gld]Fl x C3H-
gld)backcrossmice had massivelyenlarged, moderatelyenlarged, and normal lymph
nodes, respectively, and were therefore considered tobe homozygousforgld, hetero-
zygous forbothgldandm, andwildtype, respectively. The presence ofdiseased mice
in the populations obtained by mating normal to (CBA-m x C3H-gld)F1 mice and
that of nondiseased mice in the populations from crosses of the Fi to CBA-m and
TABLE III
Incidence of Lymphadenopathy in Various Hybrids Originating
from Crosses between Two of CBA-m, CBA- +, OH-gld,
C3H-Ipr, C3H- +, MRL-lpr, and MRL- + Mice
Crosses
No. of
mice observed
No. with
lymphadenopathy
CBA-m x C3H-+ 21 0(0)
CBA- + x C3H-gld 21 0(0)
CBA-m x C3H-gld 101 101 (100)
CBA-+ x C3H-lpr 25 0(0)
C3H-gld x C3H-Ipr 24 0(0)
CBA-m x C3H-Ipr 77 77 (100)
CBA-m x MRL- + 26 0(0)
CBA-m x MRL-W 30 30(100)524 NEW ALLELE OF Ipr LOCUS, Ipr's
TABLE IV
Tests of allelism of the Mutant Gene, m, with the gld or Ipr
Gene by Observation of Lymphadenopathy in Backcross
Populations Obtained by Mating (CBA-m x C3H-gld)FI to CBA
CBA-m, C3H- +, or C3H-gld and (CBA-m x C3H-Ipr)Fj
to CBA- + or CBA-m Mice
C3H-gld mice clearly demonstrates that the mutant gene is not allelic with gld. In
contrast, all of 226 ([CBA-m x C3H-lpr]Ft x CBA-m) but none of 96 ([CBA-m x
C3H-lpr]F1 x CBA-+) backcross mice developed lymphadenopathy (Table IV). It
is, therefore, very reasonable to conclude that the mutant gene may be allelic with
or lie on the same chromosome in close proximity to lpr. The former possibility is
more likely, since the mutant gene and lpr can be estimated to exist within 0.62 cM
from the absence of crossing over in the sum total of 322 backcross mice.
In conclusion, the new mutant gene is considered to be allelic with lpr, but able
to complement gld in induction of lymphadenopathy, and therefore is named lpr'g
(lpr complementing gld).
Comparison of Lymphoproliferation among gld/gld, lpr/lpr, lpt`e/lpr`g lpr/lpr`g, and +/
gld +/lpr'9 (gld-lpr'g) Genotypes. The course oflymphoproliferation was investigated
by weight measurements oflymph nodesand spleens in CBA-m, C3H-gld, C3H-lpr,
(CBA-m x C3H-gld)Fj, and (CBA-m x C3H-lpr)Fl mice (Table V). In CBA-m
mice, the superficial lymph nodes and spleens commenced to enlarge at 2 mo of
age, andthe internal lymph nodes didso at 3 mo of age. Lymphadenopathybecame
more severe with age. However, the mesenteric lymph nodes did not show marked
hyperplasia. At 5 mo of age, the profile of lymphoproliferation was practically the
same in CBA-m, C3H-gld, C3H-lpr, and (CBA-m x C3H-lpr)Fl mice, except for
thenormal size ofmesenteric lymph nodes in the first. In contrast, lymph node hyper-
Backcross population Sex
No. of
mice observed
No. with
lymphadenopathy
(CBA-m x C3H-g1d)Fj Male 71 16 (22.5)
x CBA-+ Female 66 14 (21 .2)
(CBA-m x C3H-gld)Fl Male 20 3 (15.0)
x C3H-+ Female 19 4 (21 .1)
Total 176 37 (21 .0)
(CBA-m x C3H-gld)Fj Male 62 45 (72.6)
x CBA-m Female 58 44 (75.9)
(CBA-m x C3H-gld)Fl Male 28 23 (82.1)
x C3H-gld Female 19 14 (73.7)
Total 167 126 (75.4)
(CBA-m x C3H-Ipr)Ft Male 55 0(0)
x CBA-+ Female 41 0(0)
Total 96 0 (0)
(CBA-m x C3H-Ipr)Fi Male 116 116 (100)
x CBA-m Female 110 110 (100)
Total 226 226 (100)MATSUZAWA ET AL.
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TABLE V
Lymph Node and Spleen Weights in CBA-m, OH-gld, C3H-lpr, (CBA-m x C3H-lpr)F1,
and (CBA-m x C3H-gld)Fi Mice
Strain
CBA-m
C3H-g1d
C3H-lpr
(GBA-m x
C3H-Ipr)Fl
(GBA-m x
C3H-g1d)Fj
' The weight of a lymph node was expressed as <5 mg when it was normal (see the text). Therefore, the
combined superficial and internal lymph node weights are <50 and <40 mg, respectively, when all lymph
nodes are normal in size .
t Mean t SE. The value with or without ± SE means that some or all lymph nodes were normal, respec-
tively.
plasia and splenomegaly were of significantly lesser severity in (CBA-m x C3H-
gld)F1 mice. The superficial lymph nodes were >5 and >15 times heavier than the
normal ones at 3 and 5 mo of age, respectively, but the internal lymph nodes and
spleen were practically normal and sporadically hyperplastic, respectively. More in-
terestingly, although lymphoproliferation was generally progressive after 5 mo of
age in CBA-m, C3H-gld, C3H-lpr, and (CBA-m x C3H-lpr)Fl mice (data not
shown), it became far less severe at 10 and 12 mo of age in (CBA-m x C3H-gld)F1.
Hyperplasiawas sporadic even in the superficial lymphnodes, and allinternal lymph
nodeswere normal in size in many mice, suggesting regression oflymphadenopathy.
In addition, the peripheral leukocyte count at 5 mo of age was in the normal range
in (CBA-m x C3H-gld)F,, but abnormally higher in the other mice (data not
shown). Thesefindings support theconclusion ofthe geneticstudies that the mutant
gene, lpr'g, is allelic with lpr but nonallelic with gld.
Comparison of Surface Antigens of Lymph Node Cells among gld/gld, lpr/lpr, lprc911prc9,
lpr/lpr'g, andgld-lpr'g Genotypes.
￿
Lymph node cells from 5-6-mo-old mice with these
5
5
5
5
Male
Female
Male
Female
5
5
5
6
2,507 t
2,697 t
3,873 f
4,787 t
408
277
433
574
461 t 61
522 t 75
755 * 51
1,098 f 264
183
212
137
132
t 41
t 25
t 33
t 37
403 t
629 t
621 t
1,387 t
20
55
106
325
3 Male 4 285 f 60 <40 60 1 7 128 ± 11
3 Female 4 308 t 70 <42 t 1 80 f 11 153 t 23
5 Male 7 929 1 53 <140 t 38 77 f 9 225 1 38
5 Female 7 763 1 87 <119 f 34 44 1 6 199 1 31
10 Male 5 <351 1 81 <40 41 t 2 133 1 9
10 Female 5 <282 t 62 <41 t 1 91 t 44 116 t 11
12 Male 5 <313 f 52 <44 t 4 38 ± 2 117 ± 8
12 Female 5 <277 t 61 <104 t 64 32 t 2 176 t 60
Age Sex
No.
of mice
observed
Combined
Superficial
lymph
nodes
lymphnode weight (mg)'
Internal Mesenteric
lymph lymph
nodes nodes
Spleen
weight
mo mg
2 Male 5 <72 ± 21 <40 47 1 6 103 1 5
2 Female 6 <75 f 4 <40 48 1 3 135 f 11
3 Male 9 436 f 86 <59 t 10 121 t 40 414 f 49
3 Female 9 350 1 41 <54 t 7 51 t 5 450 f 28
5 Male 8 2,596 t 329 422 t 66 49 t 10 693 t 190
5 Female 8 4,320 t 432 1,185 t 184 86 t 14 1,306 ± 181
5 Male 5 4,138 t 279 1,292 t 165 286 ± 78 649 ± 87
5 Female 5 4,321 t 246 1,072 t 136 243 t 49 754 t 99526
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genotypes were examined for their reactivity to a panel of antibodies (Table VI).
As expected from the genetic studies, the proportions of cells positive for sIg, Ly-
5(B220), Thy-1, Lyt-2, and L3T4 were essentially the same in gld/gld, lpr/lpr,
lpr'911pi1g, lpr/lprrg, and gld-lpr'g mice. As already reported in C3H-gld and C3H-lpr
(7), CBA-m mice were also characterized by the major population of Thy-1+, Ly-
5(B220)+, Lyt-2-, L3T4- cells in enlarged lymph nodes, as compared with CBA-+
and C3H-+ normal mice. The presence of such anomalous lymphoid cells was fur-
ther confirmed by two-color flow cytometric analyses (data not shown). The results
indicate that the combination ofgld-lpr`g can induce the anomalous differentiation
of T cells as do gld/gld, lpr/lpr, and lpr`g/lpr`g.
SerumIg andAnti-DNA Antibody Levels.
￿
Hyperimmunoglobulinemia and antinuclear
antibodies are the important characters of mice homozygous for lpr or gld. As ex-
pected from the genetic studies, serum IgM and IgG levels, and anti-ssDNA and
anti-dsDNA antibody titers, were abnormally higher in CBA-m (Table VII), as in
C3H-gld (3) and MRL-lpr mice (4). Moreover, the anti-ssDNA antibody titer was
compared among normal, mutant, andhybrid mice (Table VIII). It was significantly
higher in CBA-m, (CBA-m x C3H-lpr)F1, C3H-lpr, and C3H-gldmice, which de-
velopedmassivelymphoid hyperplasiabut remained at insignificant or very low levels
in (CBA-m x C3H-gld)F1, with slighter lymphadenopathy and the other normal or
hybrid mice completely free from the disease. This supports the genetic conclusion
that lpr'g is allelic with lpr but not with gld.
Histological Examination of CBA-m Mice.
￿
Infiltration of lymphoid cells were fre-
quently seen in thelivers, lungs, andkidneys from 6-mo-old CBA-m mice. However,
these organs had no pathologic lesions characteristic of autoimmune disease, and
were especially free from interstitial pneumonitis reported in C3H-gld(3), and glo-
merulonephritis and vasculitis reported in MRL-lpr (17). The absenceof renalpatho-
logic lesions might be due to the CBA background genes, since renal and vascular
diseases were found in some of lpr1 9 mice considered to have 75% or more MRL
genetic background (data not shown) . This also supports the conclusion that lprrg
is a new allele of the lprlocus. The basic histopathological and immunopathological
features of CBA-m mice are reported in greater detail elsewhere (18).
TABLE VI
Expression of Cell Surface Antigens by Lymph Node Cells from Normal, Mutant,
and Hybrid Mice Aged 5-6 mo
Mean percent positive cells.
Lymph node
cells from: Genotype
No. of
mice observed slg
Cell surface antigens
Ly-5(B220) Thy-1 Lyt-2 L3T4
C3H-+ +/+ 3 16' 15 81 21 56
C3H-lpr 1pr/1pr 6 8 86 81 4 10
C3H-gld gld/gld 5 5 86 83 4 9
CBA-+ +/+ 3 15 12 84 20 63
CBA-m 1pr'e/1pr'e 6 2 90 96 4 8
(CBA-m x C3H-lpr)Fi lpr`s/lpr 5 6 83 91 6 12
(CBA-m x C3H-gld)F1 +/gld +/lpr`e 5 13 73 87 8 14MATSUZAWA ET AL.
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TABLE VIII
IgG Anti-ssDNA Antibody Levels in Normal, Mutant, and Hybrid
Mice Aged 5-6 mo
Discussion
Autoimmune mice homozygous for lpr or gld develop massive lymphoprolifera-
tion and associated autoimmune processesleading to autoantibody production and
autoimmune kidney disease (2, 3, 19). Although gldand lpr are not allelic (1-3), a
large body of evidence has accumulated to demonstrate that both genes have many
anomalous phenotypic manifestations in common: (a) most lymphoid cells from en-
larged lymph nodes are Thy-1+, Ly-1+, Lyt-2- , L3T4- , Ly-5(8220)+, Ly-6+, Ly-
22+, Ly-24+, sIg- , ThB- , la- , HSA", and PC.1+ (7, 20, 21); (b) the anomalous
cells show the same profile of bindinglectins (7); (c) they are refractory to stimula-
tion with antigen or mitogenanddo notproduceIL-2 or IFN-'Y (7, 22-24); (d) spleen
andlymph node cells producehigh levels ofc-mybRNA (22, 23); and (e) serum IgM,
IgG, and IgA levels and anti-ssDNA and anti-dsDNA antibody titers are elevated
(2, 3, 24). In addition, the xidgene has similar modifying effects on both genes (25).
Based on these striking parallels between phenotypes of the two nonallelic genes,
it has been suggested that gld and lpr may represent alterations in two different en-
zymes that actin acommon metabolicpathway ofmajorinportance to Tcell differen-
tiation and function (7, 20).
The mutant mice (CBA-m) reported here also develop massivelymphadenopathy
similar in severity and profile of lymph node hyperplasia and splenomegaly to that
in gld or lpr homozygotes (Table V). Genetic studies have provided evidence that
the mutation is a single autosomal recessive gene like gld and lpr, which are not al-
lelicwith each other (Tables I and II). To oursurprise, however, this gene interacted
with eithergldor lprto induce lymphoproliferation(Table III). Furthergenetic anal-
yses demonstrated that the mutant gene is not allelic with gldbut exists within 0.62
cM on the same chromosome or is allelic with lpr (Table IV). Thus, the mutant
gene was named lp7'9, an lpr gene complementing gld in induction of lympho-
proliferation.
The conclusion of the genetic studies has been supported by many phenotypic
features common to gld/gld, lpr/1pr, lp?'9/lprcB, lpr/lpr'g, and gld-lpr'g genotypes. Lym-
Mouse Genotype
No.
of mice
observed
IgG
anti-ssDNA
antibody level
A¢o5
CBA-+ +/+ 11 0.042 t 0.006"
(CBA-+ x CBA-m)Fl +/lprng 7 0.047 t 0.009
CBA-m 1pr`9llpr'9 12 0.420 t 0.061
(CBA-m x C3H-lpr)Fl 1pr's/Ipr 14 0.531 t 0.047
(CBA-+ x C3H-lpr)Fl +/1pr 10 0.006 t 0.003
C3H-Ipr lpr/lpr 14 0.301 ± 0.043
(CBA-m x C3H-gld)F1 +/gld +/lpr'g 12 0.034 t 0.008
(CBA-+ x C3H-gld)Fi +/gld 9 0.021 t 0.004
C3H-gld gld/gld 8 0.278 t 0.025
(C3H-gld x C3H-lpr)Fi +/gld +/lpr 12 0.004 f 0.001
' Mean t SE.MATSUZAWA ET AL.
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phoid cells from enlarged lymph nodes of C3H-gld, C3H-lpr, CBA-m, (CBA-m x
C3H-gld)Fi, and (CBA-m x C3H-lpr)Fi mice showed the same profile of surface
markers: Thy-1+, Ly-1+, Lyt-2-, L3T4-, Ly-5(B220)+, Ly-6+, Ly-24+, sIg, and la-
(Table VI and unpublished data). Expression oftheTCR protein on these abnormal
cells was diminished in CBA-m, (CBA-m x C3H-lpr)F,, and (CBA-m x C3Hg1d)Fl,
as in MRL-lpr mice (26) (unpublished data). However, Southern blot analysis of
lymph node cell-derived DNA revealed polyclonal lymphoproliferation with TCR-
a gene rearrangements in C3H-gld, C3H-lpr, CBA-m, (CBA-m x C3H-gld)F,, and
(CBA-m x C3H-lpr)Fi, as reported in C3H-gldmice (27) (unpublished data). These
results clearly support the idea that both gldand lpr cause abnormal differentiation
ofTcells through the same mechanism. On the other hand, lymphadenopathy was
far more massive in C3H-gld, C3H-lpr, CBA-m, and (CBA-m x C3H-lpr)Fl than
in (CBA-m x C3H-gld)Fi mice (Table V), and antinuclear and anti-DNA antibody
levels were abnormally high in the first four strains ofmice, but in the normal range
in thelast (18) (Table VIII). These findings are reasonable in thelight ofthe distinct
allelism oflpr'g with gld, and they suggest that the cooperation between lpr'g and g1d
may be sufficient to develop anomalous T cells but insufficient to induce autoanti-
bodies, and thatthe anomalous lymphocytes inmassivelyenlargedlymphnodes may
have an important role in autoantibody formation. In terms ofgld-Ipfg interaction,
it is ofgreat interest that 1pr has been shown not to be totally recessive, since some
B cell hyperactivityis expressedin a heterozygous state (28). It may be possible that
lp~g functions in a heterozygous state to produce a protein that may be slightly
different from the product of 1pr and can effect gld.
Thediscovery ofthe lpfg gene in CBA mice has provided strong evidence for the
similarities between the syndromes induced by gld and lpr, and strongly suggests
that both genes may influence the same point of a common metabolic pathway of
majorimportanceto thedifferentiation andfunction ofT cells. WebelievethatCBA-
lpr`g mice will provide an experimental material vital to elucidation at the molec-
ular and gene levels ofthe mechanism by which gld and lpr induce the abnormal
differentiation and functions of lymphocytes in mice.
Summary
Several mice with generalized lymphadenopathy were found in the CBA/K1Jms
(CBA)colony maintained at our institute. Anewmutant strain ofmice that develop
massivelymphoid hyperplasiaat 100% incidence within 5 mo afterbirth was estab-
lished by crossing these diseased mice. Genetic studies on lymphadenopathy were
conducted in Fl, F2, and backcross populations from crosses between mutant CBA
(CBA-m) and various inbred strains of mice. The results supported the control of
lymphadenopathy bya single autosomal recessivegene. SinceC3H/Hegld/gld(C3H-
gld), MRL/MpJ-lpr/lpr (MRL-1pr), andC3H/HeJ-lpr/lpr(C3H-lpr) mice develop the
same type of lymphoid hyperplasia, allelism ofthe mutant gene withg1d or lprwas
tested by investigating lymphadenopathy in Fi and backcross populations from
crosses between CBA-m and C314-gld, MRL-lpr, or C3H-lpr mice. The gene was
confirmed to be allelic with lpr but not with gld. Interestingly, however, the mutant
gene interacted with g1d to induce less severe lymphadenopathy. Thus, the mutant
gene was named lpr'g, an lprgene complementing gld in induction oflymphoprolifer-
ation. The genetic conclusion was supported by the same profile ofsurface markers530
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of lymphoid cells with gld/gld, lpr/lpr, lp7C9/lprCB, lpf9/lpr, and +/gld +/lpr'9 genotypes,
as well as by massive lymph node hyperplasia and high titers of autoantibodies in
the first four genotypes, but slight hyperplasia and insignificant autoantibody produc-
tion in the last. The discovery of lpr19 provided strong genetic evidence for the
parallels between anomalous phenotypes of gld and lpr, and CBA/K1Jms-lpr`g/lpf9
mice will contribute to elucidation of the mechanism of induction of the same ab-
normal differentiation and functions of lymphocytes by gld and lpr.
Receivedfor publication 6 October 1989.
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